Dr. Carolyn Baglole has been awarded a grant as part of the Boehringer Ingelheim Innovation in Understanding ILD (BUILD) program, in recognition of her research on idiopathic pulmonary fibrosis, a rare but fatal lung disease for which there is no cure and about which little is known. In an interview with the Reporter, Baglole talks about how her research could shed some much-needed light on this deadly disease. Read more.

—April 2017